Bevacizumab and temozolomide in patients with first recurrence of WHO grade II and III glioma, without 1p/19q co-deletion (TAVAREC): a randomised controlled phase 2 EORTC trial

Martin van den Bent, M Klein, Marion Smits, JC Reijneveld, Pim French, P Clement, FYF de Vos, A Wick, PJ Mulholland, MJB Taphoorn, J Lewis, M Weller, OL Chinot, J.M. Kros, Iris de Heer, T Verschuere, C Coens, V Golfinopoulos, T Gorlia, A Idbaih

Research output: Contribution to journalArticleAcademicpeer-review

73 Citations (Scopus)
Original languageUndefined/Unknown
Pages (from-to)1170-1179
Number of pages10
JournalLancet Oncology
Issue number9
Publication statusPublished - 2018

Cite this